Market Signal Briefing

On December 6, 2025, Litecoin, a prominent cryptocurrency, is grappling with volatile market dynamics as its price movement piques the interest of traders and analysts. Currently valued at approximately $150, Litecoin is under scrutiny for its potential to surge to $500, a target that has caught the eye of many investors. The current excitement surrounding Litecoin is driven largely by bullish momentum, as traders closely monitor technical indicators and market trends for signs of an impending rally.

Litecoin, launched in 2011, is often described as the silver to Bitcoin’s gold, owing to its faster transaction times and lower fees. Over the years, it has carved out a niche for itself in the digital currency ecosystem, appealing to those who seek a more efficient alternative to Bitcoin. The cryptocurrency’s performance is often seen as a barometer for the market’s overall health. With a market capitalization exceeding $10 billion, Litecoin remains one of the top players despite increased competition.

The potential for Litecoin’s value to reach $500 serves as a beacon for investors seeking returns in a sluggish market. The cryptocurrency’s resilience in the face of economic uncertainty is underscored by a series of strategic upgrades and community-driven initiatives, including the MimbleWimble extension block, which aims to enhance transaction privacy and scalability. These developments have contributed to the bullish sentiment that currently surrounds Litecoin.

However, Litecoin’s path to $500 is fraught with challenges. The cryptocurrency market is notorious for its unpredictability, and Litecoin is no exception. Unforeseen regulatory changes or technological setbacks could hinder its progress. Furthermore, the rise of new rivals poses a threat to Litecoin’s market position. In particular, Remittix, an emerging digital asset, is capturing the attention of investors. Known for its innovative approach to cross-border payments, Remittix is marketed as offering greater upside potential.

The appeal of Remittix lies in its pioneering technology, which enables near-instantaneous transactions with minimal fees—a significant advantage in the remittance sector where traditional methods are often slow and costly. This has drawn interest from both individual and institutional investors who are eager to capitalize on its projected growth. With a market that sees billions of dollars transferred across borders each year, the potential for disruption is substantial, positioning Remittix as a formidable competitor to established cryptocurrencies like Litecoin.

In the broader context, the cryptocurrency market is undergoing a period of transformation. As governments worldwide grapple with regulatory frameworks, digital currencies are steadily gaining mainstream acceptance. This shift is evident in the growing number of businesses that accept cryptocurrency payments and the increasing interest from financial institutions in blockchain technology. The landscape is evolving, and with it, the strategies of cryptocurrency projects aiming to remain relevant.

While Litecoin’s legacy in the crypto sphere is well-established, its future is not guaranteed. The landscape is increasingly competitive, with new technologies emerging that promise to address some of the inefficiencies of older systems. For Litecoin to reach the $500 mark, it must not only maintain its current momentum but also innovate and adapt to the changing environment. The implementation of new features that improve usability and security will be crucial in attracting both new and existing users.

In contrast, Bitcoin—the original cryptocurrency—continues to dominate market discussions. Its influence is undeniable, setting trends that other cryptocurrencies often follow. However, as Bitcoin’s market matures, investors are diversifying their portfolios, seeking opportunities in alternative assets like Litecoin and newer entrants. This shift underscores the need for established cryptocurrencies to differentiate themselves to maintain their market share.

One counterpoint to the optimism surrounding Litecoin is the potential impact of macroeconomic factors. Global economic instability, driven by geopolitical tensions or financial crises, could have a ripple effect on digital currencies. In such scenarios, investors might retreat to traditional safe havens like gold, reducing demand for riskier assets like cryptocurrencies. Additionally, market manipulation remains a concern, with large holders potentially influencing price movements.

Nevertheless, market analysts remain optimistic about Litecoin’s prospects, citing its strong community support and historical performance as indicators of long-term growth potential. The cryptocurrency’s ability to adapt and evolve in response to market demands will ultimately determine its success. As the industry matures, Litecoin must navigate the fine line between innovation and stability to maintain its relevance.

In conclusion, while Litecoin’s journey to a $500 valuation is plausible, it is not without its hurdles. The rapidly evolving market demands agility and forward-thinking from all participants. For Litecoin, this means continuing to build on its strengths while addressing the competitive pressures posed by new entrants like Remittix. As the digital currency landscape shifts, investors will be closely watching to see how Litecoin positions itself in this dynamic environment. The coming months will be crucial in determining whether Litecoin can capitalize on its current momentum and chart a course toward sustained growth.

Post Views: 8

Sat, 6/12/2025 - 22:00

XRP has declined by nearly 60% in its burn metric amid the unexpected price reversal that has seen the price record notable daily declines.

Cover image via U.Today

Amid the declining crypto market trend, the XRP network activity has also taken a sharp turn from the decently high levels it has seen in recent days to a very low level.

As of Saturday, Dec. 6, data from XRPSCAN shows that the total number of XRP burned as fees has dropped from 462 XRP on Dec. 5 to just 186 XRP today.

Notably, this marks a massive 59.7% decline in the XRP daily burn volume, suggesting significantly reduced network activity amid the broad crypto market uncertainty.

HOT Stories

Is XRP rebound still possible?Although the XRP burn metric has not proven to be a key determinant of its potential price action, the massive slowdown in the metric shows an overall downtrend in XRP’s on-chain movements, which shows that the demand for the asset for payments has been relatively low over the last day.

Historically, slowdowns like this fee-driven burn activity have often come at a time when the broader crypto market is slipping into another pullback phase.

Thus, XRP might be entering another correction phase despite the short-lived resurgence witnessed earlier in the week. Amid this negative trend, all major cryptocurrencies, including Bitcoin, are trading lower than previous levels over the past 24 hours.

You Might Also Like

Data from CoinMarketCap shows that XRP has declined by nearly 2% over the last day, trading at around $2.03 as of writing time.

While the decline in the burn metric may not be used to predict what the next XRP price action will be, it hints at cooling momentum despite the recent XRP ETF hopes, reflecting a drop in payment transactions from institutions and retailers and also a drop in network movement.

Despite these negative on-chain metrics, investors have remained optimistic about a potential breakout for XRP, with many expressing belief that the leading altcoin could still reclaim the crucial $3 level before the end of the year.

This resilience portrayed by the XRP community is driven by the rapidly growing inflows pulled in by the existing XRP ETFs that have continued to show strong daily performance.

Related articles

Ethereum is gaining momentum, and several technical signals suggest that a significant move could be on the way. With key support levels holding and bullish patterns forming, the market may be setting up for a notable upside.

Golden Pocket Rejection: Confirming The High-Risk Scenario
In a recent update on X, analyst Luca referenced his recent market commentary, noting that Ethereum price action unfolded exactly as he had anticipated, with the price tapping into the lost high-timeframe support range. This range aligned with the golden pocket between the 0.5 and 0.618 Fibonacci retracement levels, and the price rejected there, confirming the high-risk scenario he had highlighted in advance.

Since that rejection, the price has broken below the key 0.618 Fibonacci Point of Interest (POI). However, the asset is still managing to hold above the crucial 1-Day Bull Market Support Band. Luca stressed that this band has historically served as a strong reversal spot over the last couple of months. Thus, he believes the current low-timeframe market structure is not yet fully invalidated.

ETH gearing up for major upward moves | Source: Chart from Luca on X
Despite this technical hold, the analyst reiterated his cautious approach, stating that until he sees clear signs of strength on the low-timeframes, signs that can durably confirm the bottom is in and that key support levels are properly reclaimed, he won’t scale out of his edges.

Luca concluded that until that concrete bullish confirmation materializes, the most likely outcome for the immediate future remains further consolidation. The market needs time to absorb the recent volatility and build a new base before a more durable reversal to the upside can take hold.

ETH/BTC Trendline Breakout: Market Risk Appetite Returns
Crypto analyst Paramatik outlined that a major structural event has occurred on the ETH/BTC charts: a falling trend breakout. This is a highly significant development, although Paramatik suggests that a retest of this broken trendline may occur before the upcoming Federal Reserve meeting.

The analyst provided clarity on what this breakout means for the broader market. First and foremost, this situation is interpreted as a strengthening signal for Ethereum. When ETH begins to gain value relative to Bitcoin, it typically indicates that the market’s overall risk appetite is returning, as investors shift capital from BTC to ETH.

Secondly, the gained strength in Ethereum is often the key trigger for the start of the much-anticipated altcoin season. This is because investors first shift funds from BTC to ETH, and then move capital into the riskier, smaller altcoins in hopes of achieving higher returns.

Paramatik summarized his findings by stating that this breakout in the ETH/BTC pair is not merely a technical line break; it is a harbinger of a market direction change. The analyst concluded with an analogy that the market has reached a state where every external event, even humorously irrelevant ones, could affect crypto prices.

ETH trading at $3,037 on the 1D chart | Source: ETHUSDT on Tradingview.com
Featured image from Freepik, chart from Tradingview.com

December 06, 2025 2:45 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - December 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the "Class Period"), of the important December 30, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Synopsys securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Synopsys class action, go to https://rosenlegal.com/submit-form/?case_id=44981 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 30, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements, as well as failed to disclose material adverse facts about Synopsys' business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) the extent to which Synopsys' increased focus on artificial intelligence customers, which require additional customization, was deteriorating the economics of its Design IP business; (2) that, as a result, "certain road map and resource decisions" were unlikely to "yield their intended results,"; (3) that the foregoing had a material negative impact on financial results; and (4) as a result of the foregoing, defendants' positive statements about Synopsys' business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Synopsys class action, go to https://rosenlegal.com/submit-form/?case_id=44981 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277121

Mark Thompson, chairman and CEO of CNN Worldwide, speaks onstage in New York City. (Photo by Dimitrios Kambouris/Getty Images for Warner Bros. Discovery)

Getty Images for Warner Bros. Discovery

CNN wasn’t included in Netflix’s $82.7 billion takeover of Warner Bros. Discovery—a move that, at first, might look like a glaring snub. After all, it leaves the WBD-owned news brand, one of the most recognizable in the world, out of Hollywood’s biggest deal in years. But look closer at the Netflix deal, and a different picture emerges.

There’s also a glass-half-full view, in that the Netflix–WBD deal may have spared CNN from a corporate parent that’s committed to protecting its foothold in foreign markets, even when that means agreeing to remove sensitive content.

Why Netflix didn’t buy CNNNetflix is now the world’s dominant streaming service, operating in more than 190 countries. To do that, it’s occasionally acquiesced to local censorship—removing everything from a Hasan Minhaj segment critical of Saudi Arabia to films banned in countries like Singapore and Vietnam. “We’re not trying to do ‘truth to power,’” Netflix’s chairman Reed Hastings said at the New York Times DealBook conference in 2019, when pressed specifically about the Minhaj decision.

That stance, it should go without saying, is literally the opposite of the mandate a news organization abides by.

If Netflix had absorbed CNN, imagine its reporters trying to cover the Saudi crown prince or digital surveillance in India, all while its parent company is negotiating access in those same markets. Staff would have been right to feel leery.

Which is why, in a counterintuitive way, CNN may have gotten something better by being left out of the Netflix-WBD deal. And that’s before factoring in the political landmines associated with Netflix’s other rival bidder: Paramount’s offer reportedly included investment from Saudi Arabia, while Paramount’s owner himself is close to President Trump—an entirely different set of concerns for CNN, had Paramount won the bid for WBD and gone on to combine CNN and CBS under the editorial leadership of CBS’s new EIC, Bari Weiss.

“I’ve been asked by many of you what today’s news means for us,” CNN chairman Mark Thompson wrote Friday in an internal memo, per The New York Times. “And the answer is that it will enable us to continue to roll out our strategy to secure a great future for CNN by successfully navigating our digital transition.”

Thompson said CNN will keep working closely with Discovery Global’s eventual CEO Gunnar Wiedenfels, noting that a 2026 budget for CNN with “increased investment” is already in place.

How CNN’s ownership turmoil led to this momentIt’s not hard to see why CNN staffers are probably breathing a sigh of relief.

In less than a decade, the network has already been passed from one owner to the next. In 2016, Time Warner agreed to sell the company to AT&T. AT&T rebranded the media assets as WarnerMedia, with Jeff Zucker staying on as CNN’s president. It then spun off WarnerMedia in 2022 via a $43 billion merger with Discovery, creating Warner Bros. Discovery under CEO David Zaslav.

Zucker, popular among CNN’s rank-and-file, exited in early 2022, followed by Chris Licht’s turbulent 13-month tenure, before former New York Times CEO Mark Thompson was named chairman and CEO of CNN Worldwide in August 2023.

When WBD in 2026 finishes spinning out Discovery Global, CNN will be a high-cost asset inside a business that’s in secular decline. And, for better or worse, it won’t have a Big Media parent company behind it.

Paramount Skydance CEO David Ellison speaks during the Bloomberg Screentime conference in Los Angeles on October 9, 2025. (Photo by PATRICK T. FALLON/AFP via Getty Images)

AFP via Getty Images

Will Paramount try to buy CNN?This is where things could get interesting.

Paramount CEO David Ellison reportedly wanted to buy all of WBD, compared to Netflix’s interest only in the streaming and film businesses. And while Netflix’s snub may have preserved CNN’s independence today, it also leaves open a clean path to some sort of Paramount–CNN deal later at a price the Ellisons would welcome.

To that latter point about price: When a global entertainment giant like Netflix takes a pass, it arguably makes the company that owns CNN more attractive for a buyer looking for a strategic bargain (not unlike a real-estate price correction triggered by lack of demand). What’s more, a Netflix–CNN tie-up would almost certainly have led to congressional hearings, not to mention objections from foreign regulators already skittish about Western news brands.

Open X today, and you’ll also encounter plenty of tweets from users convinced from the get-go that Netflix is going to “woke-ify” their favorite shows on HBO, so there’s also that.

MORE FOR YOU

For Paramount, there’s a case to be made that CNN is now a simpler asset to buy. A CBS News–CNN merger would instantly create one of the most powerful news operations in the country. The regulatory hurdles aren’t as high as they used to be, either, since both are national networks, and the FCC has shown flexibility as cable declines.

Long story short, CNN might have dodged the complications of a Netflix deal. But what happens if Paramount decides that it now wants to buy the 24/7 news network is still very much a live question.

About Angela Harmantas
Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government. She earned a Bachelor of... Read more

About the publisher
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.

Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.

We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.

The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.

Use of technology
Proactive has always been a forward looking and enthusiastic technology adopter.

Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.

Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.

SoundHound AI is delivering monstrous growth right now.

SoundHound AI (SOUN 0.16%) is a popular AI stock due to its growth rate and size. It's a relatively small company at a $5 billion market cap, but its revenue is rising at over 50% year over year. Despite this, its stock has sold off heavily over the past few weeks and has fallen nearly 40% from its all-time high. That's a deep sell-off, and it may have many investors wondering if now is the time to buy the stock.

What matters for a company's stock price is the future, and SoundHound AI's looks bright. I think its stock price could be much higher by 2030, and if it goes right for SoundHound AI, it's a must-buy at these levels.

Image source: Getty Images.

SoundHound AI must appeal to the consumer
SoundHound AI integrates audio recognition technology with generative AI. This isn't a new technology, as digital assistants like Siri and Alexa have utilized artificial intelligence for some time to perform tasks similar to those of SoundHound AI's product. The difference is that SoundHound AI's platform is more accurate in certain tasks, such as drive-thru ordering at a fast food restaurant.

That's just one application for SoundHound AI's software, and it's a fairly limited one. However, if its technology is deployed across every drive-thru at every fast-food restaurant in the U.S., that's a sizable market opportunity. Other areas SoundHound AI is attempting to break into are financial services, healthcare, and insurance. These industries have sizable customer service teams to handle issues and claims. If generative AI-powered agents from SoundHound AI can replace the humans who normally staff these roles, SoundHound AI could capture a massive market opportunity.

Today's Change

(

-0.16

%) $

-0.02

Current Price

$

12.78

There's just one problem: SoundHound AI isn't human. If consumers overwhelmingly reject AI replacing humans in some of these daily interactions, then SoundHound AI's software has a relatively limited application. The key is for consumers to accept AI integration, which may not occur for a few years. Technology is often rejected when it first rolls out. Many consumers initially hesitated to use credit cards online due to concerns about their information being stolen, but now, most don't think twice about making online purchases. I could see voice AI integration going the same way, as it may seem odd at first, but eventually it becomes normal and a part of daily life.

That's the bull case for SoundHound AI integration, as the bear case could be outright rejection, and its business fails for factors outside of its control. However, if you examine SoundHound AI's growth rates, it's clear that the company is performing well.

SoundHound AI's stock price could soar over the next few years
In Q3, SoundHound AI's revenue rose 68% year over year to $42 million. In Q2, management stated that it has visibility to 50% organic growth rates for the "foreseeable future." Q3 results backed that statement up, but what will SoundHound AI's stock price look like by 2030 if it can sustain that growth through 2030?

Over the past 12 months, SoundHound AI's revenue totaled $148 million. Should SoundHound AI sustain that growth rate through the end of 2030, its revenue would total $1.24 billion. SoundHound AI's stock would deserve a premium valuation for a software stock if it can deliver that level of growth for five years, so I'll price the stock at 20 times sales. That would give SoundHound AI a market cap of nearly $25 billion -- about a 400% rise.

SOUN Revenue (TTM) data by YCharts

At nearly $12 per share now, that would price the stock at about $60 per share. That's a huge rise and would make it a must-buy stock. But remember, its success is tied to consumer adoption. If the consumer accepts AI integration, then I could see this stock price coming to fruition. If they reject it, don't be surprised if SoundHound AI's stock is a market loser.

U.S. President Donald Trump's plan to take government equity stakes in strategic industries doesn't apply to major defense firms, the head of Boeing's defense unit said on Saturday, in contrast to previous comments by a senior government official.

Selective Treg modulator gotistobart (BNT316/ONC-392) showed a reduction in the risk of death by more than half compared to standard of care chemotherapy and a manageable safety profile in the first of two stages of the global Phase 3 trial PRESERVE-003 in patients with squamous non-small cell lung cancer (“sqNSCLC”) who have progressed on prior immunotherapy plus chemotherapyMedian OS with gotistobart has not been reached at almost 15 months of follow-up, compared to a median OS of 10 months observed with chemotherapyAs a chemotherapy-free monotherapy, gotistobart has the potential to become an alternative to traditional cytotoxic treatment for a patient population with high unmet medical needGotistobart was granted Fast Track Designation by the U.S. Food and Drug Administration (“FDA”) for the treatment of patients with metastatic NSCLC whose disease progressed on prior anti-PD-(L)1 therapy MAINZ, Germany, and ROCKVILLE, USA, December 6, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) and OncoC4, Inc. (“OncoC4”) today presented data from the non-pivotal dose-confirmation stage of the global randomized Phase 3 trial PRESERVE-003 (NCT05671510) for gotistobart (also known as BNT316 or ONC-392), a tumor microenvironment-selective regulatory T cell (“Treg”) depletion candidate, targeting CTLA-4 in patients with metastatic squamous non-small cell lung cancer (sqNSCLC). Gotistobart demonstrated a clinically meaningful overall survival (“OS”) benefit compared to standard-of-care chemotherapy and a manageable safety profile in sqNSCLC patients whose disease had progressed following anti-PD-(L)1 therapy and platinum-based chemotherapy. Data from the non-pivotal stage of the trial are being presented today in an oral presentation at the IASLC ASCO 2025 North America Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer in Chicago, Illinois, USA.

“With a median survival of less than a year, advanced squamous NSCLC remains an aggressive and difficult-to-treat lung cancer1,2. Survival outcomes have improved in recent years due to advances in immunotherapy and combination regimens. However, patients who progress on anti-PD-(L)1 inhibitor treatment face a poor prognosis, leaving them only with the option of chemotherapy or palliative care,” said Byoung Chul Cho, M.D., Ph.D., Lead Investigator and Professor at the Division of Medical Oncology, Yonsei Cancer Center, Seoul. “We are encouraged by the median overall survival still not being reached for patients treated with gotistobart at almost 15 months of follow-up, and we are excited to continue to investigate the candidate’s potential in the ongoing pivotal stage of the trial.”

The analysis from the non-pivotal stage of the global Phase 3 trial included 45 metastatic sqNSCLC patients who received gotistobart as monotherapy, compared with 42 metastatic sqNSCLC patients who received chemotherapy (docetaxel) as second or later line of systemic therapy. At the data cut-off on August 8, 2025, 87 patients with sqNSCLC had been randomized to either gotistobart 6 mg/kg with two 10 mg/kg loading doses (N=45) or docetaxel 75 mg/m2 (N=42). The OS rate at 12 months was 63.1% for gotistobart compared to 30.3% for docetaxel. At a median follow-up of 14.5 months, patients in the gotistobart treatment arm had not yet reached the median OS, while the docetaxel treatment arm achieved a median OS of 10 months. The data showed that the gotistobart arm reduced the risk of death by 54% compared to the docetaxel treatment arm (HR=0.46, 95% CI: 0.25–0.84; nominal p-value 0.0102). The safety profile of gotistobart was consistent with previously established data and remained manageable. Grade ≥3 treatment-related adverse events (“AEs”) were reported in 19/45 (42.2%) patients in the gotistobart treatment arm versus 20/41 (48.8%) patients in docetaxel treatment arm. The pivotal stage of the Phase 3 trial is ongoing in more than 160 sites globally.

“Gotistobart is designed to selectively deplete tumor-infiltrating regulatory T cells within the tumor microenvironment. The data presented today showed encouraging signals for our approach to translating our deep understanding of the immune system into meaningful survival benefits for patients with squamous NSCLC,” said Prof. Özlem Türeci, M.D., Co-Founder and Chief Medical Officer at BioNTech. “With its unique mode of action, we are investigating gotistobart both as a monotherapy and in synergistic combinations with other modalities. Our goal is to deliver transformative treatment options that provide meaningful and durable benefits for patients.”

“Gotistobart represents a step forward in our goal of offering a chemotherapy-free treatment option for patients with advanced squamous NSCLC, a population with limited therapeutic choices and a lack of actionable biomarkers to guide treatment,” said Pan Zheng, M.D., Ph.D., Chief Medical Officer and Co-Founder at OncoC4. “The encouraging data presented today underscore the potential of gotistobart to address the unmet medical needs. We look forward to continuing to jointly explore the potential of the novel mechanism of action and advance clinical development for patients who have not benefited from currently approved immunotherapy.”

About the PRESERVE-003 trial
PRESERVE-003 (NCT05671510) is a two-stage, open-label Phase 3 trial evaluating the efficacy and safety of gotistobart as monotherapy compared to the standard-of-care chemotherapy (docetaxel) in sqNSCLC patients, who have progressed on PD-(L)1 inhibitors and platinum-based chemotherapy. The non-pivotal stage of the trial originally included all NSCLC patients. The ongoing pivotal stage is currently enrolling patients with sqNSCLC. During the ongoing pivotal stage, approximately 500 patients are planned to be enrolled at clinical sites in various countries and regions, including Australia, Belgium, Canada, China, Germany, Italy, the Netherlands, Spain, South Korea, Türkiye, the United Kingdom and the United States. The primary endpoint is overall survival. Secondary endpoints include overall response rate, progression-free survival and safety profile.

About gotistobart (BNT316/ONC-392)
Gotistobart (BNT316/ONC-392) is a tumor microenvironment-selective Treg depletion candidate developed jointly by BioNTech and OncoC4. As a pH-sensitive monoclonal antibody, gotistobart is designed to enable CTLA-4 protein recycling. After binding to the CTLA-4 receptor on the cell surface, the complex is internalized, and the pH change causes the antibody to unbind, allowing CTLA-4 to return to the surface to preserve the immune checkpoint function at peripheral organs and to enhance anti-tumor immunity in the tumor microenvironment3. Gotistobart is currently in late-stage clinical development as monotherapy and as a component of combination therapy in various cancer indications. Gotistobart has received Fast Track Designation from the U.S. Food and Drug Administration (“FDA”) in 2022 for the treatment of patients with metastatic NSCLC whose disease progressed on prior anti-PD-(L)1 therapy and Breakthrough Therapy Designation from China’s National Medical Products Administration (“NMPA”) in 2025.

Multiple trials are ongoing, including a pivotal Phase 3 trial (PRESERVE-003; NCT05671510) in patients with metastatic squamous NSCLC, a Phase 2 trial (PRESERVE-004; NCT05446298) in patients with platinum-resistant ovarian cancer, a Phase 2 trial (PRESERVE-006; NCT05682443) in patients with metastatic castration-resistant prostate cancer, and a Phase 1/2 open-label dose escalation trial (PRESERVE-001; NCT04140526) in patients with advanced solid tumors. BioNTech also evaluates gotistobart in combination with its mRNA cancer immunotherapy candidate BNT116 in a signal seeking cohort of the ongoing Phase 1 trial (LuCa-MERIT-1; NCT05142189).

About NSCLC
Non-small cell lung cancer (“NSCLC”) covers all epithelial lung cancers other than small cell lung cancer and includes squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung. It is the most common type of lung cancer, accounting for up to 85% of cases4, with risk factors ranging from smoking to asbestos exposure and pulmonary fibrosis5. Around 25% of all lung cancer cases are attributed to the subtype squamous cell carcinoma (SCC)6. With a 5-year relative survival rate of 15% and a median overall survival of 11 months in the United States (2000-2017), sqNSCLC is a devastating disease with limited treatment options7. Current standard-of-care includes surgery and radiotherapy in combination with chemotherapy8. Treatment options for second-line therapy after first-line immunotherapy and chemotherapy are limited to chemotherapy or palliative therapy in advanced/metastatic sqNSCLC, and remain more limited than for non-squamous NSCLC5.

About BioNTech
Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel investigative therapies for cancer and other serious diseases. BioNTech exploits a wide array of computational discovery and therapeutic modalities with the intent of rapid development of novel biopharmaceuticals. Its diversified portfolio of oncology product candidates aiming to address the full continuum of cancer includes mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies such as antibody-drug conjugates (ADCs) and innovative chimeric antigen receptor (CAR) T cell therapies. Based on its deep expertise in mRNA development and in-house manufacturing capabilities, BioNTech and its collaborators are researching and developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global and specialized pharmaceutical collaborators, including Bristol Myers Squibb, Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, Genmab, MediLink, OncoC4, Pfizer and Regeneron.

For more information, please visit www.BioNTech.com.

BioNTech Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, but not limited to, statements concerning: the collaboration with OncoC4; BioNTech and OncoC4’s ability to successfully co-develop and co-commercialize gotistobart (also known as BNT316 or ONC-392), if approved; the rate and degree of market acceptance of gotistobart, if approved; the initiation, timing, progress, and results of BioNTech’s research and development programs, including data from the non-pivotal dose-confirmation stage of the global randomized Phase 3 trial PRESERVE-003 and statements regarding the expected timing of initiation, enrollment, and completion of trials and related preparatory work and the availability of results, and the timing and outcome of applications for regulatory approvals and marketing authorizations, including expectations regarding the potential indications in which gotistobart may be approved, if at all; the targeted timing and number of additional potentially registrational trials, and the registrational potential of any trial BioNTech may initiate; and discussions with regulatory agencies. In some cases, forward-looking statements can be identified by terminology such as “will,” “may,” “should,” “expects,” “intends,” “plans,” “aims,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words.

The forward-looking statements in this press release are based on BioNTech’s current expectations and beliefs of future events and are neither promises nor guarantees. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond BioNTech’s control and which could cause actual results to differ materially and adversely from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as risks associated with clinical data, and including the possibility of unfavorable new preclinical, clinical or safety data and further analyses of existing preclinical, clinical or safety data; the nature of clinical data, which is subject to ongoing peer review, regulatory review and market interpretation; the impact of tariffs and escalations in trade policy; competition related to BioNTech’s product candidates; the timing of and BioNTech’s ability to obtain and maintain regulatory approval for its product candidates; BioNTech’s ability to identify research opportunities and discover and develop investigational medicines; the ability and willingness of BioNTech’s third-party collaborators to continue research and development activities relating to BioNTech’s development candidates and investigational medicines; unforeseen safety issues and potential claims that are alleged to arise from the use of products and product candidates developed or manufactured by BioNTech; BioNTech’s and its collaborators’ ability to commercialize and market its product candidates, if approved; BioNTech’s ability to manage its development and related expenses; regulatory and political developments in the United States and other countries; BioNTech’s ability to effectively scale its production capabilities and manufacture its products and product candidates; and other factors not known to BioNTech at this time.

You should review the risks and uncertainties described under the heading “Risk Factors” in BioNTech’s Report on Form 6-K for the period ended September 30, 2025 and in subsequent filings made by BioNTech with the SEC, which are available on the SEC’s website at www.sec.gov. These forward-looking statements speak only as of the date hereof. Except as required by law, BioNTech disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise.

About OncoC4
Based in Rockville, Maryland, OncoC4 is a privately held, late clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biologicals for the treatment of cancer and immunological diseases. OncoC4’s pipeline features assets with first-in-class and best-in-class potential targeting both novel and well validated targets across oncology and immunological diseases. Among them, AI-081 is a fully owned bispecific antibody candidate targeting PD-1 and VEGF. ONC-841 is a first-in-class anti-SIGLEC10 antibody currently in a Phase 2 trial for oncology indications and being explored for neurodegenerative diseases. OncoC4 has a strategic collaboration with BioNTech to co-develop gotistobart (BNT316/ONC-392), a tumor microenvironment-selective Treg depletion candidate targeting CTLA-4, in multiple solid tumor indications, including an ongoing pivotal clinical trial in squamous non-small cell lung cancer.

More information: www.oncoc4.com.

CONTACTS

BioNTech:

Investor Relations
Douglas Maffei, Ph.D.
[email protected]

Media Relations
Jasmina Alatovic
[email protected]

Media Relations
Helen Schiltz
[email protected]

1 Paz-Ares L, et al. (2018) Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer. N Eng J Med. 379:2040-2051.
2 Zhou, Caicun et al. (2024) A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004), Cancer Cell, Volume 42, Issue 2, 198 - 208.e3

3 Zhang Y et al. (2019) Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy. Cell Res. 29:609-627.
4 Sung H. et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 71(3):209-249
5 National Cancer Institute at the National Institutes of Health (2025) Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version, online at:  https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq#_37_toc
6 Zhang Y. et al. (2023) Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncol. 24(11):1206-1218.
7 Hu, Sheng et al. (2021) Prognosis and Survival Analysis of 922,217 Lung Cancer Patients from the US Based on the Most Recent Data from the SEER Database (April 15, 2021), International Journal of General Medicine, Volume 14, 9567-9588.
8 American Cancer Society (2025) Treatment Choices for Non-small Cell Lung Cancer, by Stage, online at: https://www.cancer.org/cancer/types/lung-cancer/treating-non-small-cell/by-stage.html

Discovering why Broadcom became such a hot stock makes it easier to find the next opportunity.

Broadcom (AVGO +2.28%) has been one of the best stocks to hold over the past decade. It has rallied by almost 4,000% during that stretch, including a return of 10x over the past five years.

Investors can't expect those types of returns from Broadcom over the next decade. The artificial intelligence (AI) chipmaker's market cap would exceed the annual U.S. GDP if the stock soared by almost 4,000%.

That's why investors look for the next Broadcom. They want to be on the ground floor before a stock rallies by 4,000% over the past decade.

Some investors refer to these types of gains as "generational returns," but such opportunities occur far more frequently than once in a generation. The jaw-dropping rallies for Tesla and Palantir Technologies are only separated by a few years.

Broadcom shares several key factors in common with other high-growth stocks that have delivered what many investors would consider generational returns. Knowing what made Broadcom into the company it is today can help you identify the next long-term winner.

Image source: Getty Images.

Broadcom solves an important problem
The biggest companies solve incredible problems, and Broadcom is no exception. The company has been producing semiconductor chips long before the advent of AI, and Broadcom chips were once found in every iPhone. Its tech forms the foundation that allows other companies to solve big problems.

Broadcom chips are in many computers, wireless routers, video game consoles, and other devices. Those products have significant consumer demand, but they also require chips to operate. Broadcom isn't the only chipmaker, but it is a leader in the industry. Computers and other critical products cannot function without chips.

Today's Change

(

2.28

%) $

8.69

Current Price

$

389.72

AI has increased the demand for advanced chips, and it's been a boon for Broadcom. The technology can revolutionize the world far more than the internet in its best-case scenario.

Tesla CEO Elon Musk recently shared on X that AI can solve hunger, disease, and poverty. Sundar Pichai, the CEO of Google and its parent company, Alphabet, also said that AI is "more important than fire or electricity."

If AI is that important, then chipmakers like Broadcom are that important, by extension. Broadcom powers the technology that business leaders have said can solve hunger and is more important than electricity. Very few companies are solving that type of problem, and that's why Broadcom is one of the largest corporations on the planet.

Considering which companies are solving problems that can become consequential may lead to the next Broadcom.

The chipmaker serves large customers
There are two ways to grow a business. You can either focus on serving a few high-paying customers or offer products or services to a large customer base. While Walmart does a good job of attracting millions of people to its stores each day, Broadcom doesn't have as many customers.

The company also works with smaller enterprises, but most of its revenue comes from large corporations, especially tech giants that want chips. Broadcom has a deep partnership with Google that includes designing custom AI chips, and that got Meta Platforms' attention. Facebook's parent company is discussing a multibillion-dollar deal for Google's chips, which bodes well for Broadcom.

When Broadcom signs a new customer, it can result in a multibillion-dollar deal, and such transactions can significantly boost the stock price. Investors saw that play out recently, with Broadcom soaring by more than 10% on news that Meta Platforms was in talks to buy Google's AI chips.

Examining how the largest companies allocate their resources can reveal promising growth stocks, especially when they are just starting to gain momentum.

The company has used acquisitions to fill in gaps
Broadcom has made several acquisitions over the years that prepared it for the AI boom. Ironically, one of the biggest acquisitions was when Avago acquired Broadcom for $37 billion and rebranded as Broadcom. That's why Broadcom trades under the ticker AVGO instead of a symbol that more closely resembles Broadcom's spelling.

That decision made Broadcom more competitive against other chipmakers and significantly helped in attracting large customers. The firm also acquired semiconductor firm LSI Corporation for $6.6 billion in 2013. More recently, Broadcom acquired VMware to expand its software business.

Other tech giants have acquired their way to more market share. Google bought YouTube to get an early start in video content, Amazon bought Whole Foods to boost its grocery store footprint, and Meta Platforms bought Instagram to capitalize on a high-engagement social network.

Each of those companies has made additional acquisitions and investments. It's part of becoming a corporate giant like Broadcom.

This AI stock checks the boxes to become the next Broadcom
Broadcom has long-term customers and offers essential technology, and Iren (IREN 3.55%) also checks those boxes. Instead of creating AI chips, Iren creates AI data centers at scale and just signed a five-year, $9.7 billion deal with Microsoft. It also supplies energy, which is currently the major bottleneck in AI development.

Iren already has multiple gigawatts and AI data centers to support additional deals, and co-CEO Dan Roberts recently told CNBC that the company "can't meet demand fast enough." That's a good bullish indicator, especially since most AI demand is coming from tech giants with lots of money to spend.

Today's Change

(

-3.55

%) $

-1.65

Current Price

$

44.80

Iren's data centers are optimized for the rigorous energy demands of AI tools and software. Regular data centers aren't good enough for this new tech boom because they can't handle AI workloads. Iren is still a small company with a market cap below $15 billion, but it's solving the same exact problems as Broadcom.

As Iren grows, expect the AI data center provider to acquire smaller companies to increase its market share. That will further put it on the path to becoming the next Broadcom.

Robinhood's financials have been picking up steam in recent quarters.

When it comes to investing, Robinhood (HOOD 3.74%) has positioned itself as the easy-to-use, "cool" option. It has become the go-to investing platform for many Gen-Z and millennial investors. It hasn't been all smooth sailing for Robinhood since its July 2021 initial public offering (IPO), but this past year has been a much-appreciated bounce back.

In the past year (through Dec. 3), Robinhood's stock is up nearly 246%, meaning a $1,000 investment then would be worth close to $3,460 today.

HOOD data by YCharts

Much of Robinhood's recent impressive stock performance can be attributed to its impressive financial performance. In the third quarter (Q3), its revenue increased 100% year over year to $1.27 billion, and its net income (a profit measure) increased 271% to $556 million.

Today's Change

(

-3.74

%) $

-5.13

Current Price

$

131.95

Robinhood's recent financial performance shows it isn't just a speculative growth company anymore. It's a profitable company that's showing signs of sustainability. Just two years ago, in Q3 2023, it lost $85 million, so this has been a fairly quick turnaround.

The company has also been expanding its business beyond stock buying. It now has its hand in prediction markets (though it faces legal pushback) and runs a cryptocurrency exchange called Bitstamp. Its stock platform will remain its bread and butter, but it's good to see it trying to diversify its business a bit.

Stefon Walters has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

The Trump administration said it will forgive the last $11 million of a civil fine against Southwest Airlines that stems from the carrier's 2022 holiday meltdown that stranded some 2 million passengers after nearly 17,000 flights were canceled.

The Transportation Department under the Biden administration in late 2023 fined the Dallas-based airline $140 million, though the agency then credited the airline with all but $35 million of that amount because of its compensation to customers.

In an order filed Friday, the Transportation Department cited Southwest's more than $1 billion investments in its technology and operation since the holiday meltdown as reason for the additional credit. Southwest was due to make the last payment next month.

"Southwest Airlines is grateful to [Transportation] Secretary [Sean] Duffy and the DOT Team for recognizing Southwest's significant investments in modernizing our operations," Southwest said Saturday. "During the last two years, Southwest successfully completed an operational turnaround that directly benefits our Customers with industry leading on-time performance and percentage of completed flights without cancellations."

Read more CNBC airline newsDelta says government shutdown cost it $200 million, but forecasts strong travel demand into 2026The government shutdown is over. The air traffic controller shortage is notBoeing stems cash burn for first time since 2023 but takes $4.9 billion charge on 777X delaysAmerican Airlines is late to the luxury travel boom. Can it catch up?

NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Perrigo securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Perrigo. class action, go to https://rosenlegal.com/submit-form/?case_id=48085 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 16, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made materially false and/or misleading statements and or failed to disclose that: (1) the infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance; (2) Perrigo needed to make substantial capital and operational expenditures above Perrigo’s outwardly stated cost estimates to remediate the infant formula business; (3) there were significant manufacturing deficiencies in the facility for Perrigo’s infant formula business; (4) as a result of the foregoing, Perrigo’s financial results, including earnings and cash flow, were overstated; and (5) as a result of the foregoing, defendants’ positive statements about Perrigo’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Perrigo class action, go to https://rosenlegal.com/submit-form/?case_id=48085 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

Meta is developing new mixed reality glasses under the codename Phoenix, according to Business Insider — but their release date has been pushed back from the second half of 2026 to the first half of 2027.

The Facebook parent company already sells VR headsets and Ray-Ban smart glasses, but these glasses sound a bit different; their format factor would reportedly be similar to the Apple Vision Pro, with a puck-like power source.

BI says it’s seen memos from Meta executives announcing the delay, apparently after meetings in which CEO Mark Zuckerberg told them to take more time to make the business sustainable and deliver higher quality experiences.

The company’s metaverse leaders Gabriel Aul and Ryan Cairns reportedly wrote that the delay is “going to give us a lot more breathing room to get the details right.”

Bloomberg reported earlier this week that Meta plans to slash its metaverse budget by up to 30%.

NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Primo Water Corporation (NYSE: PRMW) between June 17, 2024 and November 8, 2024, both dates inclusive, and/or (ii) purchasers of common stock of Primo Brands Corporation (NYSE: PRMB) between November 11, 2024 and November 6, 2025 (the “Class Period”), of the important January 12, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Primo Brands securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Primo Brands class action, go to https://rosenlegal.com/submit-form/?case_id=47890 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 12, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, Primo Brands formed following the November 8, 2024 merger between Primo Water and BlueTriton Brands, is a branded beverage company that offers beverage products across a variety of formats, channels, and price points. According to the lawsuit, throughout the Class Period, defendants misrepresented and failed to disclose key facts about the merger between Primo Water and BlueTriton Brands, including facts regarding the progress of the merger integration. Defendants issued a series of materially false and misleading statements that led investors to believe the merger would accelerate growth, generate transformative operational efficiencies, achieve meaningful synergies, and deliver strong financial results, and that the merger integration was proceeding “flawlessly.” When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Primo Brands class action, go to https://rosenlegal.com/submit-form/?case_id=47890 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

You'd likely be impressed with your gains, but the volatility could be hard to stomach.

Since Bitcoin became mainstream, there has been an influx of new cryptocurrencies. In most cases, these cryptocurrencies have little to no tangible use for the public and are nothing more than pump-and-dump schemes for their creators and insiders.

However, a few non-Bitcoin cryptocurrencies have gained traction and present real-world use cases, with XRP (XRP 0.30%) being one of them. At the time of writing, XRP's price sits at $2.20. That's up 465% in the past three years, meaning a $1,000 investment made then would be worth around $5,650 today.

Image source: Getty Images.

So what exactly does XRP do?
XRP was created with the goal of making cross-border transactions faster and cheaper. Right now, most cross-border transactions are costly because they involve multiple financial institutions, including local banks and correspondent banks. The cost to send money can be as high as 7% in some cases. By removing intermediaries, XRP can make these transfers virtually instantly for fractions of a cent.

Today's Change

(

-0.30

%) $

-0.01

Current Price

$

2.03

XRP's use case hasn't caught on in the mainstream, but the projected growth of the cross-border payments market has kept optimism high among XRP enthusiasts.

Like any cryptocurrency, XRP's volatility makes it challenging to store value. However, it stands out among cryptocurrencies for its mission and real-world use case.

Stefon Walters has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Bitcoin and XRP. The Motley Fool has a disclosure policy.

As of December 2025, Bitcoin is valued at $89,618, bringing its total market capitalization to $1.78 trillion. The leading cryptocurrency has experienced a 24-hour trading volume of $45.76 billion, with its price fluctuating narrowly between $88,420 and $91,290. This range-bound movement indicates a period of market indecision where participants are neither ready to trigger a massive sell-off nor confident enough to push the price significantly higher.

The current price stability of Bitcoin is marked by a lack of clear direction, reflecting the ongoing tug-of-war between optimistic bulls and cautious bears. This stalemate hints at a larger global economic context where investors weigh potential risks against prospective returns. Recently, Bitcoin has witnessed significant volatility, influenced by macroeconomic factors, including inflation and interest rate changes. These elements have forced traders to adopt a more nuanced approach rather than reacting with panic or exuberance.

Historically, Bitcoin has been volatile, with dramatic price swings often linked to regulatory news, technological developments, or shifts in demand and supply. In previous years, major announcements such as the introduction of futures trading, or regulatory clampdowns in key markets like China, have sent ripples through the cryptocurrency space. As such, today’s steadiness might suggest a maturing market where factors other than speculation are gaining influence.

Despite this maturity, Bitcoin’s price is still susceptible to external shocks. For instance, changes in U.S. monetary policy or geopolitical tensions could alter investor sentiment abruptly. The Federal Reserve’s decisions on interest rates have historically impacted risky assets, including cryptocurrencies. With a strong U.S. dollar, for example, Bitcoin might struggle to gain traction as investors seek safer, more stable returns. On the other hand, a depreciating dollar could bolster Bitcoin as an alternative store of value.

Adding complexity to the current scenario is the global regulatory environment. More nations are adopting frameworks to regulate cryptocurrencies, attempting to harness the technology’s potential while mitigating associated risks. The European Union’s recent advancements in cryptocurrency regulation aim for comprehensive oversight, which could impact Bitcoin’s price stability. Simultaneously, countries like El Salvador have embraced Bitcoin as legal tender, creating a unique dynamic that could influence market behavior.

While the adoption of Bitcoin and other cryptocurrencies has grown, skepticism remains. Critics often point to environmental concerns associated with Bitcoin mining, which demands substantial energy resources. Despite efforts to shift towards renewable energy, this remains a contentious issue, potentially influencing regulatory actions and investor sentiment negatively.

Moreover, the increasing competition from other cryptocurrencies poses another challenge. Ethereum, with its smart contract capabilities, and newer entrants focusing on scalability and efficiency, offer alternatives that could divert interest away from Bitcoin. The growing ecosystem of decentralized finance (DeFi) and non-fungible tokens (NFTs) also showcases innovation beyond Bitcoin’s original scope, prompting investors to diversify their portfolios.

In parallel, the emergence of central bank digital currencies (CBDCs) represents another frontier. Countries like China are pioneering digital yuan initiatives, which could redefine how digital transactions occur, potentially impacting Bitcoin’s role. If CBDCs gain widespread acceptance, they could offer a state-backed alternative that challenges Bitcoin’s appeal as a transactional medium.

Despite these challenges, Bitcoin’s foundational role in the cryptocurrency ecosystem remains unshaken. Institutional adoption continues to rise, with financial giants and companies integrating Bitcoin into their investment strategies. This institutional interest not only validates Bitcoin’s potential but also infuses the market with a layer of stability that retail investors alone could not achieve.

However, the journey forward is fraught with uncertainties. A significant risk is the potential for technological disruption. Advances in quantum computing, for instance, could, in theory, undermine Bitcoin’s cryptographic security, posing a daunting challenge. Although current assessments suggest such threats are still distant, the crypto community must remain vigilant.

Another risk involves market manipulation. Given its decentralized nature, Bitcoin is susceptible to price manipulation by large holders, known as “whales,” who can influence market trends and sentiment with substantial transactions. Such dynamics could lead to price distortions that might mislead less experienced investors.

In conclusion, while Bitcoin’s price has stabilized within a narrow range, signaling caution rather than capitulation, the broader landscape suggests a mix of opportunities and obstacles. The interplay of regulatory developments, technological innovations, and geopolitical factors will continue to shape its trajectory. As Bitcoin navigates through these complex waters, its ability to maintain relevance depends on adaptability and resilience against emerging challenges in the rapidly evolving digital asset landscape.

Post Views: 12

Texas has officially become the first U.S. state to acquire Bitcoin for a government strategic reserve, purchasing $5 million worth of the digital asset on November 20 at roughly $87,000 per BTC. The move was confirmed by Lee Bratcher, president of the Texas Blockchain Council, who said the initial allocation was executed through BlackRock’s iShares Bitcoin Trust (IBIT) while the state finalizes its self-custody framework.

The purchase marks a significant milestone in state-level adoption of Bitcoin as a reserve asset. Texas lawmakers had explored creating a strategic Bitcoin reserve as early as last year, emphasizing that it would not rely on taxpayer funds. The initiative became law in June when the governor formally established the Texas Strategic Bitcoin Reserve.

Bratcher, who played a key role in crafting and advancing the legislation through the state Senate, noted that self-custody remains the long-term goal. “Texas will eventually self-custody bitcoin,” he said, “but while that RFP process takes place, this initial allocation was made with BlackRock’s IBIT ETF.”

As president and founder of the Texas Blockchain Council, an industry association representing more than 100 companies, Bratcher has been a central advocate for positioning Texas as a national leader in Bitcoin and blockchain innovation. The state’s inaugural purchase signals what advocates view as a rising trend of governmental interest in digital assets as part of future financial strategy.

On a recent Friday, as Bitcoin’s value dipped below the significant $90,000 mark, a previously inactive wallet from 2012 suddenly became active. This wallet, untouched for over 13 years, transferred 1,000 BTC, which at current valuations equates to roughly $89.4 million. This move occurred at block height 926566, and shortly afterward, another wallet mirrored this action by transferring another 1,000 BTC.

The awakening of these Bitcoin wallets, often referred to as “sleeping” wallets due to their prolonged inactivity, has sparked interest and speculation within the cryptocurrency community. These wallets, which have remained untouched for long periods, represent substantial sums of money. In this case, the activation involved Bitcoin that had not moved since the early days of the cryptocurrency, highlighting both the enduring potential of Bitcoin and the trust that holders have had in its value over time.

Bitcoin, launched in 2009, has experienced a volatile journey, with its price experiencing dramatic rises and falls. Despite its fluctuations, Bitcoin has seen a general upward trend, bolstering its reputation as a potential store of value comparable to gold. The recent movement of these large sums of Bitcoin raises questions about the motivations behind these transactions. It could suggest a strategic decision by the holders to capitalize on market conditions or to diversify their holdings.

Historically, the movement of dormant Bitcoin can lead to speculation about market impacts. In some cases, significant transactions have influenced short-term price swings due to the sudden increase in available supply. Additionally, such activities can lead to discussions about the security and anonymity of Bitcoin transactions. Despite the digital currency’s pseudonymous nature, large movements attract attention and can sometimes be traced to specific entities or individuals.

The resurgence of these wallets is not unprecedented but is noteworthy due to the substantial value they represent. In the context of Bitcoin’s history, similar occurrences have been observed when prices reach new highs or lows, suggesting that some long-term holders might choose these moments to realize profits or reallocate assets.

The significance of these movements extends beyond mere financial interest; they also highlight the technological resilience of Bitcoin. The cryptocurrency’s underlying blockchain technology ensures that these transactions, even when dormant for years, are executed securely and efficiently. The blockchain’s decentralized nature means that no central authority can interfere with these transactions, reinforcing the trust in the systemic integrity of Bitcoin.

While such movements can stimulate the market and generate interest, they also carry risks. Large movements of Bitcoin can lead to price volatility, which, while beneficial for traders, can pose risks for less experienced investors or those holding Bitcoin as a long-term store of value. Moreover, there’s the potential for these actions to influence regulatory discussions. As governments worldwide continue to refine their approaches to cryptocurrency regulation, significant movements can either prompt stricter policies or encourage more open dialogues about the role of digital currencies in the global financial system.

Regulatory landscapes have evolved significantly since Bitcoin’s inception. In its early days, Bitcoin operated in a largely unregulated space, perceived by many governments as a fringe technology. However, as its adoption has grown, so too has the regulatory framework surrounding it. Countries like the United States, the European Union, and others have developed detailed regulations addressing cryptocurrency exchanges, trading practices, and taxation. These developments underscore the importance of balancing innovation with consumer protection and financial stability.

Comparatively, other nations like El Salvador have taken adventurous steps, even legalizing Bitcoin as legal tender. This move is part of a broader strategy to increase financial inclusion and integrate more citizens into the global economy. The interplay between regulatory environments and cryptocurrency activities remains a critical area for future development.

Despite these advances, challenges persist. Cybersecurity remains a primary concern for both individuals and exchanges, as the history of Bitcoin is marred with high-profile hacks and thefts. Enhanced security measures and user education are vital to safeguarding assets in the digital age. Additionally, the environmental impact of Bitcoin mining continues to provoke debate. The energy-intensive nature of mining has led to criticisms about sustainability, prompting some regions to consider restrictions or bans on mining activities.

As Bitcoin continues to develop, its ability to adapt to changing market conditions and regulatory landscapes will be crucial. The reactivation of long-dormant wallets underscores the confidence some long-term investors have in Bitcoin’s enduring value. However, this confidence is tempered by the potential for volatility and regulatory challenges.

Ultimately, the reactivation of these wallets is a testament to Bitcoin’s lasting impact on the financial landscape. As the digital currency continues to evolve, it remains a focal point for discussions on decentralization, financial innovation, and the future of money. Whether as a speculative asset or a potential hedge against inflation, Bitcoin’s role in the global economy is set to remain significant, with these recent transactions serving as a reminder of its dynamic and ever-changing nature.

In conclusion, the movement of dormant Bitcoins illustrates both the opportunities and complexities inherent in the cryptocurrency market. As Bitcoin navigates its path forward, the lessons learned from these movements will shape the future of digital currencies and their place in the world economy. The next chapter in Bitcoin’s story will likely continue to challenge traditional financial paradigms, offering novel opportunities and posing new questions for investors, regulators, and technologists alike.

Post Views: 15

Polytrade has taken a pivotal role in shaping the future of real estate tokenization by becoming the Lead Development Anchor for the Integra Consortium, a move revealed on December 6, 2025. This strategic alliance positions Polytrade at the forefront of developing a blockchain specifically designed for the global real-estate market. The collaboration aims to address the unique challenges associated with real-world asset (RWA) tokenization by leveraging Polytrade’s extensive experience and technological innovations.

Historically, real estate has been a cornerstone of wealth creation and investment, but its integration into blockchain technology has been fraught with complexities. Traditional blockchains have struggled to meet the stringent requirements of data management, compliance, and valuation essential for institutional real estate markets. Since 2021, Polytrade has been a leader in bridging this gap, establishing a vibrant ecosystem that includes issuers, liquidity providers, and enterprise partners. This rich tapestry of relationships highlighted the need for a blockchain tailored to the regulated nature of real estate assets.

Polytrade’s journey over the past five years has been marked by significant collaborations with major banks, funds, and multinational enterprises. Through these partnerships, including a notable association with Mastercard, Polytrade has gathered insights that underscore the necessity for a specialized blockchain environment. Such an environment is now being realized with Integra, a blockchain purposefully built to embed asset information, compliance proofs, and market applications seamlessly within its architecture.

Integra’s vision is ambitious. By creating a vertically integrated ecosystem, it seeks to streamline the management and exchange of tokenized real estate assets at scale. Announced in a whitepaper on November 28, Integra’s comprehensive approach includes developing native applications and a stablecoin alongside the blockchain infrastructure. This model not only promises efficiency but also introduces new revenue streams through stablecoin yield and native decentralized applications (DApps) fees, differentiating it from other Layer 1 solutions that primarily rely on gas and transaction fees.

The consortium backing Integra is formidable, comprising major real estate asset managers such as Nitya Capital and technology innovators like Digishares. This collaboration ensures that Integra starts with a solid foundation, capable of handling substantial transactions, including hundreds of millions in rent, sales, and exits from its consortium members. Such scale is poised to redefine what an Asset-Specific Layer 1 (L1) blockchain can achieve in the marketplace.

Polytrade’s role extends beyond just technical development. With a robust distribution network and a mature RWA marketplace already in place, Polytrade is set to accelerate the adoption and integration of Integra’s blockchain. By facilitating the onboarding of institutional partners and managing asset flows, Polytrade enhances Integra’s value proposition, potentially setting a new standard for blockchain-enabled real estate operations.

In recognition of its community, Polytrade has announced that holders of its $TRADE token will receive an allocation of Integra’s native token, $IRL. This gesture underscores Polytrade’s commitment to its base as it transitions to this new venture. While details of the token allocation are still pending, the promise of participation in Integra’s future underlines the strategic alignment between the two entities.

The implications of this partnership are far-reaching. By merging Polytrade’s expertise with Integra’s specialized infrastructure, the consortium aims to transform global real-estate markets. This collaboration is not merely about technological advancement but represents a broader ambition to redefine how real estate transactions are conducted on a global scale.

Despite the optimism surrounding this initiative, it is not without risks. The integration of traditional real estate markets with blockchain technology poses significant regulatory challenges. Different jurisdictions have varying legal frameworks governing digital assets, which could complicate the rollout of such a system. Furthermore, the dependence on blockchain stability and cybersecurity presents ongoing risks that must be managed to maintain trust among institutional investors and regulators.

The Integra Consortium represents a significant step forward in the evolution of blockchain technology tailored to real-world applications. By harnessing Polytrade’s institutional knowledge and technological prowess, the consortium is poised to pioneer a new era in real estate asset management. As the blockchain landscape continues to evolve, such collaborations will be crucial in defining and mainstreaming innovative solutions that bridge traditional and digital asset markets.

In conclusion, the partnership between Polytrade and Integra is a testament to the transformative potential of blockchain technology in real estate. By addressing the specific needs of this market, the consortium not only positions itself as a leader in asset tokenization but also sets the stage for broader adoption and integration of blockchain solutions across industries. As the world increasingly moves towards digital transformation, initiatives like this are likely to pave the way for more secure, efficient, and accessible asset management systems.

Post Views: 8

Terraform Labs founder Do Kwon should serve at least 12 years behind bars for his role in the spectacular $40 billion implosion of the Terra ecosystem, U.S. federal prosecutors said on Thursday.

While Kwon’s team recently requested a 5-year sentence, U.S. officials contended that the massive scope of his crimes cries out for this lengthy prison sentence to discourage any future similar behavior.

Though Do Kwon faced up to 25 years in federal prison for his crimes, prosecutors agreed in August that they would push for up to 12 years as part of a plea deal reached with the ex-crypto mogul, where he pleaded guilty to conspiracy to commit fraud and wire fraud. 

In a sentencing submission filed on Thursday to the U.S. District Judge Paul Engelmayer for the Southern District of New York, DOJ attorneys argued that Kwon deserves a harsh sentence to avoid “unwarranted sentencing disparities” with other, similar cases — namely, that of FTX founder Sam Bankman-Fried.

In a 2023 jury trial, Bankman-Fried was convicted on seven counts of fraud and conspiracy for his role in the collapse of his $32 billion crypto empire. A judge later sentenced the former billionaire crypto wunderkind to 25 years in prison. 

Advertisement
 

“Judge Kaplan imposed a sentence of 25 years on Bankman-Fried, who, like Kwon, perpetrated a fraud of staggering proportions in his twenties and then attributed his brazen criminal conduct in part to youth and inexperience,” the prosecutors postulated.

The prosecutors also slammed Kwon’s legal team for claiming the Terra founder should receive a “far shorter sentence” than Celsius founder Alex Mashinsky, who was sentenced to 12 years in prison earlier this year for multi-billion-dollar fraud.

The Terra-Luna Implosion
Kwon, a 34-year-old South Korean citizen, found himself at the heart of a global financial implosion in 2022 when two cryptocurrencies he created, the algorithmic stablecoin UST and its sister token Luna, quickly crashed to zero, wiping out over $40 billion in investor money and triggering a cascading crisis in the cryptocurrency market. 

The resulting contagion event led to the downfall of several crypto entities in 2022, including FTX. Prosecutors claim Kwon misled investors about the risks and stability associated with the tokens. 

“Kwon deprived UST and Terra purchasers of the ability to make fully informed decisions about their purchases, and artificially inflated the value of Terraform’s cryptocurrencies, which directly enriched and raised Kwon’s profile,” they wrote in the filing.

The former Terraform boss fled the chaos, only to be arrested in Montenegro in 2023 while attempting to fly to Dubai with a forged passport. He was deported to New York earlier this year after an extremely lengthy jurisdictional contest.

“Kwon’s misconduct, the consequences of his crime, and his reaction to the discovery of his scheme all warrant a substantial prison term,” prosecutors noted. “Indeed, the circumstances of the offense, standing alone, would weigh strongly in favor of a maximum sentence.”

Kwon will be sentenced in Manhattan on December 11.

Ethereum, despite its recent woes, has the potential to rise to as high as $6800 according to a recent RSI analysis by an influencer on X (formerly Twitter). The second-largest cryptocurrency by market capitalization is currently trading right around the $3100 price level as the bulls try to chalk out a new strategy going into 2026. Ethereum has also enacted the latest Fusaka upgrade on its blockchain, a bold new initiative for scaling the legacy decentralized network.

Ethereum to Appreciate to $4300, Potential to Reach $6800
Skyodelic, the analyst in question, has recently been upbeat about Ethereum because of a bullish trend emerging from deep within the current bearish setup. He tweeted:

“$ETH looks ready to push much higher

In the last 5 years every single time the 1D RSI has gone from overbought, down to oversold, and then broken the trend(green circle)…

It has pumped a minimum of 45%.

Advertisement
 

That takes us to $4,300.

That is just the minimum, worst case scenario this is a bear market etc

The average is 111%…. Which would take us to $6,800.

Basically, whenever $ETH goes from overbought to oversold, and the breaks the downtrend…

It’s pushes very nicely.

Only one out of those 5 scenarios did $ETH double bottom after the break of trend… the other 4 times the bottom was in.

It broke that downtrend today quite convincingly.”

The tweet ended with graph:

Image Source: X
The analyst has identified key RSI trends from the last 3.5 years that predict a major price rebound is on its way. The focus is on the decisive breakout from the downward oversold territory that has dominated the market since the October 11 crash, forcing the larger crypto market on its back foot. 

Ethereum, as the graph indicates, has massive upside potential because of its successful rebound from lower RSI levels, which showed the digital currency was struggling in deep bearish territory below 30, hardly a week ago. Now, the situation has changed somewhat with the RSI recovering to 50 and the index feeling relatively safe around the $3.1k valuation.

A textbook reaction to this pattern would result in the premier programmable cryptocurrency rising to $4.3k, a figure which has been attributed as the “minimum worst case scenario”. In the best-case scenario, ETH could rise to $6800, representing a 111% price appreciation from current levels, as we see a clear shift from oversold to neutral RSI.

The Future
The future is tricky to predict, but in this case, the changeover from the oversold to neutral RSI territory is an important one that cannot be ignored by traders however, if we have already kick-started the next iteration of the bear market, which some analysts fear, low RSI levels mean nothing, as in such a scenario, the cryptocurrency can remain in oversold territory for long periods of time. 

The remaining days of December will be crucial in determining the future course of action for Ethereum.

The recent drop in Bitcoin dominance is pointing towards a major altseason, according to one popular analyst. This could be a major development for crypto traders, as both Bitcoin and altcoins are currently reeling from sustained attacks by bearish forces that have resulted in the overall digital currency market losing more than $1 trillion in valuation since the start of October.

Falling Bitcoin Dominance to Trigger Major Altseason?
Merlijn the Trader, a popular crypto analyst on X (formerly Twitter), argues for a major altcoin boom following a Bitcoin dominance peak during this cycle. He tweeted:

“BITCOIN DOMINANCE: THE CRASH SIGNAL IS BACK.

2017: Dominance topped. Altseason. Rugpull

2021: Same setup. Same result

Advertisement
 

2025: History repeats?

This signal has never missed.

BTC.D peaks. Alts explode. Then the floor disappears.

The clock is ticking.

Don’t get trapped”

Image Source: X
According to this analyst, Bitcoin dominance peaked above 65% earlier this year and has been sliding ever since. It is trading just south of the 60% share at press time. According to the analyst, the only outcome of this major development is a full-blown altseason, followed by a major rug pull that will bring altcoins crashing down.

Historical confirms this developing pattern: BTC.D fell from 65% to 35% in early 2018 after the 2017 peak, and from 70% to 40% in mid-2021, enabling altseason gains of 10x+ before 80%+ drawdowns in alt markets. The 80%+ loss doesn’t scare altcoin investors because they have been down this road before and are prepared to deal with it.

Traders Keep Their Fingers Crossed
Altcoin holders are optimistic about a possible altseason because it will open up the market considerably and pour a lot of capital into the system. Currently, the larger crypto market, especially the altcoin scene, is quite dead and trending largely downward. There are growing fears that we won’t see a major altcoin boom this time around, which could end the 4-year crypto cycle as we know it.

The fears are well-placed because this is the first time since 2017 that Bitcoin’s new ATHs have failed to trigger an altseason in the year following a halving. Virtually all of the top altcoins are yet to record a new ATH (apart from ETH and BNB), let alone go on a bullish frenzy. 

Further complications have arisen from the manner in which BTC’s dominance has declined so far. Previously, altcoins boosted their share by rallying hard against the premier digital currency, especially the top lot like ETH, XRP, and DOGE. This year, they have been reduced to playing catch-up with BTC and haven’t given a single indication that they aim to follow suit with an altseason. So, the doubts are very much around as well, and the incoming few months are expected to be crucial in determining the future of altseasons and their place in the crypto market, which has been taken for granted. 

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

Bitcoin’s price action has been grossly dramatic throughout the year. After reaching its current all-time-high price of $126,000 in early October, the world’s leading cryptocurrency saw a rapid flip to the downside. Since reaching its October high, Bitcoin spiraled to as low as $80,500, a more than 15% negative deviation in reviewing year on year growth. 

As the market sentiment thus ostensibly leans bearish, an on-chain analysis has recently been published, proffering reasons to believe that the negative sentiment among investors could be growing stronger.

$91,000 Max Pain Point Breached After Friday Options Expiry
In a QuickTake post on CryptoQuant, crypto pundit GugaOnChain brings to light the expiry of about $3.4 billion in Bitcoin options. This expiration event, which took place on Friday, 5th December, is one that typically triggers a “gravitational force” which attracts price to itself. By extension, price tends to move towards a specific price level referred to as the Maximum Pain Point, where option buyers incur the greatest losses, and sellers realize the most profits.

Source: CryptoQuant
In this scenario, the Maximum Pain Point stood at approximately $91,000. As such, the Bitcoin price saw a rapid decline towards this mark. However, by the end of the session, Bitcoin had already slipped beneath its “gravitational force,” reaching as low as $89,500, and entering a range that amplified its buyers’ losses, while also maximizing its sellers’ (market makers) gains.

Negative Funding Rate Further Strengthens Bearish Narrative
GugaOnChain also references readings from the Bitcoin: Funding Rates metric, which tracks the average funding rate across all major perpetual futures exchanges. As the analyst explains, this metric is useful in reading the prevalent market sentiment. For example, negative Funding Rates, such as the current reading of -0.001206, typically indicate the willingness of short traders to pay the longs for their positions. As such, it is evident that the market sentiment is more bearish than bullish.

There appears to be an alignment between the negative funding rates and the sell pressure supplied by the $3.4 billion expired options and breach of the $91,000 Maximum Pain Point. GugaOnChain explains that such a correlation further strengthens the narrative that the Bitcoin market could see an additional significant drop in its price.

While the long-term market direction may be well-defined, its short-term sentiment, however, reflects a more modest stance of utmost caution.  As of press time, Bitcoin is valued at about $89,250. Over the past 24 hours, the premier cryptocurrency has lost approximately 3.38% of its value, per CoinMarketCap data.

BTC trading at $89,602 on the daily chart | Source: BTCUSDT chart on Tradingview.com
Featured image from Shutterstock, chart from Tradingview

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

contributor

Posted: December 7, 2025

Over the past day, pippin [PIPPIN] has rallied 59%, at press time, after weeks of quiet accumulation across the memecoin sector.

Its market cap jumped 33%, rising to $233.53 million from a low near $22 million on the 21st of November, breaking through previous ranges with steady momentum.

Traders are rotating back into mid‑caps, with PIPPIN delivering one of the strongest recoveries in the sector.

Source: TradingView

The daily timeframe confirms the shift, with the memecoin chart fully reclaiming long‑term resistance zones. Momentum candles now extend into levels not seen since earlier this year, giving the current rally significant weight.

Whales add $19M as retail volume jumps
According to data from BubbleMaps, 50 connected wallets bought $19 million in PIPPIN through synchronized entries.

HTX funded these addresses within narrow windows, received similar amounts of Solana [SOL], and showed almost no prior on-chain footprint. This pattern points to a coordinated buildup rather than isolated trading activity.

Source: Bubblemaps

On the 2nd of December, BubbleMaps flagged additional activity, revealing 26 addresses that withdrew 44% of all PIPPIN from Gate over the past two months, a total worth $96 million.

Source: Bubblemaps

Notably, most withdrawals hit on the 24th of October, the 23rd of November, and the majority came from newly funded wallets.

Heavy accumulation on centralized exchanges followed by structured withdrawals often signals strong conviction from well-capitalized players.

Decoding on-chain factors
CoinGlass data shows retail traders entering aggressively, with volume surging past $49 million and Open Interest (OI) rising over 38%, at press time, reinforcing each breakout attempt.

Meanwhile, market cap keeps climbing as liquidity deepens with every push.

Source: CoinGlass

Retail traders and whales are now moving in sync, turning the trend from a brief rebound into a more controlled advance. 

Buyers remain aggressive, with both spot and leveraged flows adding sustained pressure to the chart.

Final Thoughts

Whale accumulation and rising retail participation highlight strong conviction, reinforcing PIPPIN’s momentum across key resistance levels.
The question remains: Can the rally transform into a broader breakout, unlocking higher liquidity zones?